A newborn in the neonatal intensive care unit is struggling to breathe. The team needs to decide fast whether to place a breathing tube. A new bedside tool may help doctors spot these infants within the first 72 hours of life. It uses three simple factors that are already collected at birth.
This matters because preterm infants face a high risk of breathing failure. When a baby is born too early, the lungs are not fully developed. Many need help to breathe, and some need a breathing tube for invasive mechanical ventilation. This procedure can save lives, but it also carries risks. Parents and doctors want to know as early as possible who will need this support.
In the past, decisions often relied on gestational age, birth weight, or a doctor’s experience. These are helpful, but they are not precise. Some babies who seem stable can suddenly need a breathing tube. Others may be treated more aggressively than needed. A simple, accurate prediction tool could change that.
But here is the twist. This new model does not require complex tests or expensive equipment. It uses three factors that are already available at the bedside: the Apgar score at one minute, whether surfactant was given, and whether early-onset sepsis is suspected or confirmed. These are familiar to every neonatal team.
Think of the tool like a traffic light for breathing risk. Green means low risk, yellow means watch closely, and red means prepare for a breathing tube. The model gives a score that places each baby into a risk zone. This helps teams plan ahead and avoid surprises.
The study included 1,059 preterm infants admitted to a single neonatal unit within 72 hours of birth. The researchers split the group into two sets to build and test the model. They looked at 45 possible factors and used a method that selects the most useful ones. The final model used only three.
In the test set, the model performed well. It correctly identified most infants who would need a breathing tube, and it was accurate at ruling out those who would not. At the best cutoff score, about six out of ten infants who needed the tube were flagged. At the same time, more than nine out of ten who did not need it were correctly identified. The overall accuracy was about 86 percent.
The model also matched real-world outcomes closely. When the team compared predicted risk to actual results, the numbers lined up well. Decision analysis showed the tool provided a net benefit across a range of risk thresholds. This means it can help doctors make better choices than acting on gestational age alone.
But there is a catch. This study was done at one hospital. The tool needs to be tested in other centers with different babies and different care practices. External validation is the next step before widespread use.
The researchers also tested a version that used only culture-proven sepsis. The results were similar, with a slightly higher ability to distinguish between those who needed the tube and those who did not. They also found an interaction between surfactant use and sepsis. This suggests that babies with sepsis who receive surfactant may have a different risk profile. More work is needed to understand this relationship.
Experts in neonatology see promise in this approach. A simple, three-factor model is easy to adopt at the bedside. It does not require new machines or complex calculations. It can be built into electronic records or used as a quick paper checklist. The goal is to support, not replace, clinical judgment.
For parents and caregivers, this tool could mean earlier planning and fewer surprises. If a baby is flagged as high risk, the team can prepare equipment, medications, and support. If the risk is low, the team may avoid unnecessary interventions. This can reduce stress and improve care.
This does not mean the tool is ready for every hospital today.
The study has limitations. It was retrospective and done at a single center. The sample size was modest, and the infants were all from one unit. The model may not work as well in other settings. External validation is essential before routine use.
What happens next? The researchers plan to test the model in other hospitals. They will also explore whether adding other simple factors can improve accuracy. If validated, the tool could be integrated into neonatal care pathways. This could help teams act faster and more confidently for preterm infants who need breathing support.